Stem cell biobanks

Journal of Cardiovascular Translational Research

Volumn 3, Issue 2, 2010, Pages 128-134

  Bardelli, Silvana ^a  

^a Swiss Stem Cell Foundation   (Switzerland)

Author keywords

Biobank management; Degenerative diseases; Return of investment; Stem cell banking; Stem cell therapies

Indexed keywords

BIOBANK; CARDIOVASCULAR DISEASE; CELL POPULATION; CLINICAL TRIAL; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; HEALTH CARE COST; HEALTH CARE FACILITY; HEART DISEASE; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; INVESTMENT; MESENCHYMAL STEM CELL; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; STEM CELL; STORAGE; UMBILICAL CORD BLOOD; COMMERCIAL PHENOMENA; CYTOLOGY; ECONOMICS; FETUS BLOOD; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HEALTH CARE POLICY; LEGISLATION AND JURISPRUDENCE; ORGANIZATION; ORGANIZATION AND MANAGEMENT; TRANSLATIONAL RESEARCH; WORKFLOW;

BIOLOGICAL SPECIMEN BANKS; COMMERCE; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; GOVERNMENT REGULATION; GUIDELINES AS TOPIC; HEALTH POLICY; HUMANS; INVESTMENTS; ORGANIZATIONAL OBJECTIVES; RESEARCH SUPPORT AS TOPIC; STEM CELLS; TRANSLATIONAL RESEARCH; WORKFLOW; TRANSLATIONAL MEDICAL RESEARCH;

EID: 77953615588     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9143-4     Document Type: Review

References (36)

1. Auray-Blais, C., & Patenaude, J. (2006). A biobank management model applicable to biomedical research. BMC Medical Ethics, 7, E4.
2. Liaño, F., & Torres, A. (2009). Biobanks: A new tool for clinical research. Nefrologia, 29(3), 193-195.
3. Frey, M. A., Guess, C., Allison, J., & Kurtzberg, J. (2009). Umbilical cord stem cell transplantation. Seminars in Oncology Nursing, 25(2), 115-119.
4. Gluckman, E., Broxmeyer, H. A., Auerbach, A. D., Friedman, H. S., Douglas, G. W., Devergie, A., et al. (1989). Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. New England Journal of Medicine, 32(17), 1174-1178.
5. Harris, D. T. (2008). Cord blood stem cells: Worth the investment. Nature Reviews Cancer, 8(10), 823.
6. De La Selle, V., Gluckman, E., & Bruley-Rosset, M. (1996). Newborn blood can engraft adult mice without inducing graftversus-host disease across non H-2 antigens. Blood, 87(9), 3977-3983.
7. De La Selle, V., Gluckman, E., & Bruley-Rosset, M. (1998). Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood. Blood, 92(10), 3968-3975.
8. Gluckman, E., Devergie, A., Thierry, D., Esperou-Bourdeau, H., Traineau, R., Gerrota, J., et al. (1992). Clinical applications of stem cell transfusion from cord blood and rationale for cord blood banking. Bone Marrow Transplantation, 9(Suppl 1), 114-117.
9. Brunstein, C. G., & Wagner, J. E. (2006). Umbilical cord blood transplantation and banking. Annual Review of Medicine, 57, 403-417.
10. Haller, M. J., Viener, H. L., Wasserfall, C., Brusko, T., Atkinson, M. A., & Schatz, D. A. (2008). Autologous umbilical cord blood infusion for type 1 diabetes. Experimental Hematology, 36(6), 710-715.
11. Newman, M. B., Emerich, D. F., Borlongan, C. V., Sanberg, C. D., & Sanberg, P. R. (2004). Use of human umbilical cord blood (HUCB) cells to repair the damaged brain. Curr Neurovasc Res, 1(3), 269-281.
12. Staba, S. L., Escolar, M. L., Poe, M., Kim, Y., Martin, P. L., Szabolcs, P., et al. (2004). Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. New England Journal of Medicine, 350(19), 1960-1969.
13. Laughlin, M. J., Barker, J., Bambach, B., Koc, O. N., Rizzieri, D. A., Wagner, J. E., et al. (2001). Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. New England Journal of Medicine, 344(24), 1815-1822.
14. Tse, W. W., Zang, S. L., Bunting, K. D., & Laughlin, M. J. (2008). Umbilical cord blood transplantation in adult myeloid leukemia. Bone Marrow Transplant, 41(5), 465-72.
15. Robinson, S., Niu, T., De Lima, M., Ng, J., Yang, H., McMannis, J., et al. (2005). Ex vivo expansion of umbilical cord blood. Cytotherapy, 7(3), 243-250.
16. Leor, J., Guetta, E., Chouraqui, P., Guetta, V., & Nagler, A. (2005). Human umbilical cord blood cells: A new alternative for myocardial repair? Cytotherapy, 7(3), 251-257.
17. Dasari, V. R., Spomar, D. G., Gondi, C. S., Sloffer, C. A., Saving, K. L., Gujrati, M., et al. (2007). Axonal remyelination by cord blood stem cells after spinal cord injury. Journal of Neurotrauma, 24(2), 391-410.
18. Murohara, T., Ikeda, H., Duan, J., Shintani, S., Sasaki, K., Eguchi, H., et al. (2000). Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. Journal of Clinical Investigation, 105(11), 1527-1536.
19. Taguchi, A., Soma, T., Tanaka, H., Kanda, T., Nishimura, H., Yoshikawa, H., et al. (2004). Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. Journal of Clinical Investigation, 114(3), 330-338.
20. Henning, R. J., Abu-Ali, H., Balis, J. U., Morgan, M. B., Willing, A. E., & Sanberg, P. R. (2004). Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplantation, 13(7-8), 729-739.
21. Henning, R. J., Burgos, J. D., Ondrovic, L., Sanberg, P., Balis, J., & Morgan, M. B. (2006). Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplantation, 15(7), 647-658.
22. Ballen, K. K. (2005). New trends in umbilical cord blood transplantation. Blood, 105(10), 3786-3792.
23. Nietfeld, J. J. (2008). Opinions regarding cord blood use need an update. Nature Reviews Cancer, 8(10), 823.
24. Broxmeyer, H. E. (2005). Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy, 7(3), 209-218.
25. Delalat, B., Pourfathollah, A. A., Soleimani, M., Mozdarani, H., Ghaemi, S. R., Movassaghpour, A. A., et al. (2009). Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells. Hematology, 14(3), 125-132.
26. Mayani, H., & Lansdorp, P. M. (1998). Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells, 16(3), 153-165.
27. Pipes, B. L., Tsang, T., Peng, S. X., Fiederlein, R., Graham, M., & Harris, D. T. (2005). Telomere length changes after umbilical cord blood transplant. Transfusion, 46(6), 1038-1043.
28. Dickinson, A. M. (2006). Biobanks and registries for HSCT research: Potential for future individualized medicine. Int J Immunogenet, 33(3), 153-154.
29. Sullivan, M. J. (2008). Banking on cord blood stem cells. Nat Rev Cancer, 8(7), 555-563.
30. Toai, T. C., Thao, H. D., Thao, N. P., Gargiulo, C., Ngoc, P. K., Van, P. H., Strong, D. M. (2009). In vitro culture and differentiation of osteoblasts from human umbilical cord blood. Cell Tissue Bank
31. Nelson, T. J., Behfar, A., & Terzic, A. (2008). Stem cells: Biologics for regeneration. Clinical Pharmacology and Therapeutics, 84(5), 620-623.
32. Nelson, T. J., Behfar, A., & Terzic, A. (2008). Strategies for therapeutic repair: The "R3" regenerative medicine paradigm. Clin Transl Sci, 1(2), 168-171.
33. Nelson, T. J., Behfar, A., Yamada, S., Martinez-Fernandez, A., & Terzic, A. (2009). Stem cell platforms for regenerative medicine. Clin Transl Sci, 2(3), 222-227.
34. Rubinstein, P. (2006). Why cord blood? Human Immunology, 67 (6), 398-404.
35. Ballen, K. K., Barker, J. N., Stewart, S. K., Greene, M. F., Lane, T. A., & American Society of Blood and Marrow Transplantation. (2008). Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant, 14(3), 356-363.
36. Yuille, M., Van Ommen, G. J., Bréchot, C., Cambon-Thomsen, A., Dagher, G., Landegren, U., et al. (2008). Biobanking for Europe. Briefings in Bioinformatics, 9(1), 14-24